{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:18:54Z","timestamp":1787653134116,"version":"build-2736575974"},"reference-count":42,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100032752","name":"Laboratoires Th\u00e9a","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100032752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To demonstrate non-inferiority on efficacy and safety of preservative-free bimatoprost 0.01% versus preserved and higher-concentration bimatoprost formulations for the treatment of glaucoma or ocular hypertension (OHT), using a network meta-analysis (NMA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and Bayesian NMA were conducted according to a pre-registered protocol (PROSPERO: CRD420250650769) and PRISMA-NMA guidelines. Randomised controlled trials comparing monotherapies of bimatoprost (preserved or preservative-free) in adults with glaucoma or OHT were included. The primary endpoint was mean intraocular pressure (IOP) at Week 12. Conjunctival hyperaemia, were descriptively analysed. Risk of bias was assessed using the Cochrane RoB 2 tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four studies were included. The Bayesian NMA demonstrated that preservative-free bimatoprost 0.01% was non-inferior to all other bimatoprost formulations in lowering IOP, with all 95% credible intervals falling within the 1.5 mmHg non-inferiority margin. Sensitivity analyses using a frequentist model confirmed these findings. Safety analysis indicated that preservative-free bimatoprost formulations were associated with lower rates of hyperaemia compared to preserved versions. At Week 12, more patients had no hyperaemia with preservative-free bimatoprost 0.01% (57.3% vs. 43.6%) and fewer showed worsening scores (18.3% vs. 30.4%). Hyperaemia reported as an adverse event was also less frequent with bimatoprost 0.01% than 0.03% (28.6% vs. 37.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preservative-free bimatoprost 0.01% provided IOP-lowering efficacy similar to preserved or higher-dose bimatoprost, with less occurrence of conjunctival hyperaemia. Further long-term studies are needed to confirm these benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11206721261436125","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:58:47Z","timestamp":1775041127000},"page":"1373-1383","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preservative-free 0.01% bimatoprost versus other formulations for glaucoma and OHT: Systematic review and meta-analysis of efficacy and safety"],"prefix":"10.1177","volume":"36","author":[{"given":"Alina Popa","family":"Cherecheanu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Carol Davila University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Marinus Petrus","family":"Cornelis de Crom","sequence":"additional","affiliation":[{"name":"University Eye Clinic Maastricht, Maastricht University Medical Center +, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Baschet","sequence":"additional","affiliation":[{"name":"Horiana, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-292X","authenticated-orcid":false,"given":"Cindy Mary-Lynn","family":"Hutnik","sequence":"additional","affiliation":[{"name":"Western University"},{"name":"Ivey Eye Institute, St. Joseph's Health Care, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Schmetterer","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 169856, Singapore"},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"SERI-NTU Advanced Ocular Engineering (STANCE), Nanyang Technological University, Singapore 639798, Singapore"},{"name":"School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637459, Singapore"},{"name":"Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria"},{"name":"Fondation Ophtalmologique Adolphe De Rothschild, 75019 Paris, France"},{"name":"AIER Eye Hospital Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01289-8"},{"key":"e_1_3_3_3_2","first-page":"1","article-title":"European glaucoma society terminology and guidelines for glaucoma, 5th edition","volume":"105","author":"European Glaucoma Society","year":"2021","unstructured":"European Glaucoma Society. European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol 2021; 105: 1\u2013169.","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_3_4_2","first-page":"1453","article-title":"Preservative alteration of corneal permeability in humans and rabbits","volume":"25","author":"Burstein NL","year":"1984","unstructured":"Burstein NL. Preservative alteration of corneal permeability in humans and rabbits. Invest Ophthalmol Vis Sci 1984; 25: 1453\u20131457.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000192082"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2016.1202818"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-303040"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123518"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01250.x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0078-y"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700311"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6138132"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0134"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.08.002"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.10.034"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S150816"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002371"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903292649"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00224-7"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.094326"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1286"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.128454"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","unstructured":"Higgins JPT Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series 2008. doi:10.1002\/9780470712184","DOI":"10.1002\/9780470712184"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.304"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.12.003"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S41885"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S89904"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01624-9"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.06.018"},{"key":"e_1_3_3_32_2","unstructured":"European Medicines Agency. Choice of a non-inferiority margin - Scientific guideline."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S137537"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S59197"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1209481"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-022-00557-0"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002371"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214113"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4146124"},{"key":"e_1_3_3_40_2","unstructured":"Wilson CG Zhu YP Frier M et al. Ocular contact time of a carbomer gel (GelTears) in humans 1998 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1722369\/pdf\/v082p01131.pdf (1998 accessed 17 July 2025)."},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0338-6"},{"key":"e_1_3_3_42_2","first-page":"1031","article-title":"An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian lumigan(\u00ae) RC early analysis review (CLEAR) trial","volume":"8","author":"Crichton AC","year":"2014","unstructured":"Crichton AC, Nixon DR, Simonyi S, et al. An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian lumigan(\u00ae) RC early analysis review (CLEAR) trial. Clin Ophthalmol 2014; 8: 1031\u20131038.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S31330"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721261436125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721261436125","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721261436125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:24:42Z","timestamp":1787649882000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721261436125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/11206721261436125"],"URL":"https:\/\/doi.org\/10.1177\/11206721261436125","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}